Stellus is rewriting the rules for life sciences computing. The Stellus Data Platform (SDP) file system is built from the ground up for storing and processing unstructured data. It enables organizations to dramatically accelerate application performance for genomic analysis. Researchers can now process more workloads in far less time and take concrete steps to enable personalized medicine therapies for the future.
Changing the Game of Genomic Data Analysis
Stellus created its Data Plaform to address the problems of legacy storage architectures. With a new software stack built from the ground up to exploit the latest NVMe, DRAM, and NAND components, the platform sets a new standard in I/O performance for life sciences applications and unstructured Genomic data.
The Stellus Data Platform replaces traditional network attached storage’s block stores, data maps, and data caches with high-performance Key-Value Stores, key-value-over fabrics, and algorithmic data placement. At the same time, it provides file access across standard protocols like NFS and SMB, as well as newer object storage access methods like S3—all in a scalable, enterprise-ready storage system.
The Stellus Data Platform delivers these key benefits:
- Blazing-fast, consistent performance
- Composable platform flexibility
- User-mode file system
- Better economics than cloud-based alternatives
Stellus Data Platform (SDP) For Genomic Analysis
Turbocharge the Data Pipeline for Cryo-EM Applications
The Stellus Data Platform can accelerate data storage transformation and analytics activities at multiple stages in the Cryo-EM analysis pipeline. It eliminates overhead from NAS and the antiquated mapping and caching processes, so organizations can unlock the full potential of their investments in the latest processors, software frameworks, and flash storage media. Stellus Data Platform helps laboratories continually speed data through each stage of the Cryo-EM pipeline to break through the backlog and process more workloads in far less time.
With these capabilities, researchers can reduce the time needed to develop new molecular delivery mechanisms. Combined with state-of-the-art genomic analysis and new AI/ML applications—all of which benefit from SDP I/O improvements—researchers can usher in the age of personalized medicine. They can help build a future where clinicians draw on new precision therapies to target the right patient, with the right drug, in the right dosage, at the right time.
Consistently delivers more than 3 times faster application performance and more than 3 times lower latency than competing solutions.
Delivers industry-leading unstructured data performance at a fraction of the cost of existing slower solutions.
Cloud and core-based management capabilities to deliver predictive data store management, user and data analytics, and consistent performance.